SALOFALK 500MG TBL ENT 100
Active ingredient: MESALAZIN
View notice details →
News topic
All current shortage notices related to Expected end: 2027-06, structured by product, country, active ingredient and reporting period.
22 noticesActive ingredient: MESALAZIN
View notice details →Active ingredient: Human Fibrinogen
View notice details →Active ingredient: ARIPIPRAZOL
View notice details →Active ingredient: Urapidil
View notice details →Active ingredient: Urapidil
View notice details →Active ingredient: POTRAVINY PRO ZVLÁŠTNÍ LÉKAŘSKÉ ÚČELY (PZLÚ) (ČESKÁ ATC SKUPINA)
View notice details →Active ingredient: KANDESARTAN A DIURETIKA
View notice details →Active ingredient: ROSUVASTATIN
View notice details →Active ingredient: ROSUVASTATIN
View notice details →Active ingredient: AMLODIPIN
View notice details →Active ingredient: Miconazole
View notice details →Active ingredient: Risperidon
View notice details →Active ingredient: Risperidon
View notice details →Active ingredient: Risperidon
View notice details →Active ingredient: Ribavirin
View notice details →Active ingredient: Ribavirin
View notice details →Active ingredient: GLIMEPIRID
View notice details →Active ingredient: Norepinephrine
View notice details →Active ingredient: METFORMIN A SITAGLIPTIN
View notice details →Active ingredient: ATOMOXETIN
View notice details →Active ingredient: ATOMOXETIN
View notice details →Active ingredient: TECHNECIUM-(99MTC) SN2+ ČINIDLA, PRO ZNAČENÍ BUNĚK
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →